Get started
Author

Mikhail Yu. Samsonov

Observed names: M. Yu. Samsonov, M.Yu. Samsonov, Mikhail Samsonov, Samsonov, Mikhail Yu., Михаил Самсонов
Institution: R-Pharm (Russia)
ORCID: 0000-0001-7721-5059
Observed ORCIDs: 0000-0001-7721-5059, 0000-0003-2685-1623
OpenAlex ID: A5102923247
Efficacy and safety of favipiravir in a complex therapy of mild to moderate COVID-19
2020 · ", Tatiana A. Ruzhentsova, et al. · Infectious diseases News Opinions Training · 11
PDF
Analysis of Clinical Success and Molecular Mechanisms of Action of Novel Anti-glioblastoma Drugs: A Review
2024 · Sabina Abdullaeva, Vladimir Chubarev, et al. · Current Medicinal Chemistry · 7
Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression
2023 · D. S. Fomina, S. S. Andreev, et al. · PULMONOLOGIYA · 3
PDF
Artificial intelligence advancements in monoclonal antibody development technology
2026 · Manar Ammar, Mikhail Samsonov, et al. · Frontiers in Immunology · 2
PDF
Эффективность и безопасность применения фавипиравира при COVID-19 легкого и среднетяжелого течения: результаты рандомизированного исследования
2020 · Татьяна Руженцова, Павел Чухляев, et al. · 2
Complexes of Zinc(II) Chloride with N-Vinyl-, N-Allyl- and N-Propargylimidazoles: Structural, Theoretical and Biological Studies
2026 · Vladimir S. Tyurin, Victoria S. Babasieva, et al. · Pharmaceuticals · 1
Preclinical studies of antiviral activity of the RPH-137 fusion protein and molnupiravir against COVID-19
2022 · E. V. Shipaeva, O. V. Filon, et al. · Biological Products Prevention Diagnosis Treatment · 1
PDF
Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19
2022 · E.V. Tavlueva, A.E. Markarov, et al. · Infectious diseases News Opinions Training · 1
PDF
Population PK/PD Modeling and Simulation to Predict the Comparative Long-Term Efficacy of Olokizumab in Rheumatoid Arthritis Patients
2026 · Yuri Kosinsky, Ivan Azarov, et al. · Journal of Clinical Medicine
Effects of the Interleukin-6 Inhibitor Olokizumab in Patients with Rheumatoid Arthritis and CKD
2026 · Kerim Mutig, Daria Bukhanova, et al. · Journal of the American Society of Nephrology
Preclinical Efficacy and Safety Evaluation of the Novel IL-1 Binding Heterodimeric Fusion Protein RPH-104
2026 · Elena Shipaeva, Margarita Schedrova, et al. · Preprints.org
Zinc, type 2 diabetes, diabetic kidney disease: focus on hypoxia
2026 · Svetlana A. Lebedeva, Ekaterina M. Mikhailova, et al. · Frontiers in Endocrinology
PDF
CCDC 2547382: Experimental Crystal Structure Determination
2026 · Tyurin, Vladimir S., Babasieva, Victoria S., et al. · The Cambridge Structural Database
CCDC 2547383: Experimental Crystal Structure Determination
2026 · Tyurin, Vladimir S., Babasieva, Victoria S., et al. · The Cambridge Structural Database
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials)
2026 · Roy M. Fleischmann, Vibeke Strand, et al. · Rheumatology and Therapy
PDF
Comparison of methods for assessing the immunogenicity of biological drugs based on monoclonal antibodies using the example of pembrolizumab
2026 · Valeriia S. Chernyshenko, Natalia M. Faustova, et al. · Russian Journal of Biotherapy
Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period
2025 · Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, et al. · Pharmaceuticals
PDF
Key results of a multicenter, non-interventional, retrospective study of Ixabepilone therapy in routine clinical practice in patients with locally advanced or metastatic breast cancer after failure of previous therapy NIRMA
2025 · E. V. Artamonova, E. P. Anokhina, et al. · Medical alphabet
Results of a phase I clinical trial of cetuximab biosimilar (RPH-002).
2025 · Ali Mudunov, Marina Lyadova, et al. · Journal of Clinical Oncology
PDF
A Two-year Study of Cancerogenic Potential of the New Opioid Receptor Antagonist Ondelopran in Rats
2019 · K. L. Kryshen, A. A. Muzhikyan, et al. · Research and Practical Medicine Journal
PDF
Works count: 20
Citation count: 28
H-index: 3
I10-index: 1
Year
Topic
Type